Fabrication and Characterization of Sustained Release Beads of Carbamazepine by Extrusion – Spheronization Containing Carbopol®974

Autoři

  • Namita Desai
  • Satish P. Jain

Klíčová slova:

Carbamazepine, extrusion-spheronization, anti-tack, beads, sustained release

Abstrakt

 The erratic absorption of Carbamazepine, BCS Class II drug, due to low water solubility and anticholinergic properties can be minimized by developing sustained release beads. Sustained release beads of Carbamazepine were prepared using axial single screw extruder and a chequered plate spheronizer. Beads offer therapeutic advantages such as easy dispersion in the gastro-intestinal tract, lower risk of dose dumping, reduce peak plasma fluctuations and drug release is independent of gastric emptying. Extrusion-Spheronization offers matrix beads with a narrow particle size distribution obviating the coating step and is economical. The process variables studied were wet mass mixing time, extruder speed, type and die size, spheronization dwell time and disc speed and drying. The present work also discusses the role of Carbopol® 974P as a sustained release polymer for peroral delivery, which otherwise finds uses in topical and ocular delivery. Sustained release beads of Carbamazepine were successfully formulated using extrusion-spheronization. The beads were evaluated for assay, sphericity, flow properties and particle size distribution, stability, etc., and met the in vitro dissolution specifications as per USP without subsequent coating. 

Stažení

Publikováno

2012-02-16

Číslo

Vol 2 No 2 (2011)

Sekce

Research Articles

Licence

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

·         I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.

·         I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).

·         I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.

·          I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

_______________

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.